Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

16

Number of overlapping holdings

19.0%

% of WDNA's 90 holdings also in ARKG

53.3%

% of ARKG's 32 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus ARKG)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in ARKG
Overlap
NATERA INC 3.7% 5.8% 3.7%
TWIST BIOSCIENCE CORP. 3.3% 9.1% 3.3%
VERACYTE INC 2.1% 3.8% 2.1%
AMGEN INC 1.7% 1.8% 1.7%
BEAM THERAPEUTICS, INC. 1.5% 4.5% 1.5%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to ARKG
NOVOZYMES A/S-B SHARES 2.9%
ELI LILLY & CO 2.7%
BLUEPRINT MEDICINES CORP. 2.6%
VERICEL CORPORATION 2.6%
BRIDGEBIO PHARMA, INC. 2.4%
AGIOS PHARMACEUTICALS INC 1.9%
GILEAD SCIENCES INC 1.9%
UNITED THERAPEUTICS CORP 1.7%
NOVARTIS AG 1.7%
ALNYLAM PHARMACEUTICALS INC 1.6%
WDNA Underweight Relative to ARKG
RECURSION PHARMACEUTICALS, INC CLASS -7.3%
CRISPR THERAPEUTICS AG -6.4%
GUARDANT HEALTH, INC. -6.0%
ADAPTIVE BIOTECHNOLOGIES CORP. -5.8%
TWIST BIOSCIENCE CORP. -5.8%
CAREDX, INC. -4.1%
SCHRODINGER, INC. -3.6%
BEAM THERAPEUTICS, INC. -3.0%
PERSONALIS, INC. -2.6%
ABSCI CORPORATION -2.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY